Endoscope-enhanced fluorescence-guided microsurgery increases survival in patients with glioblastoma

被引:4
作者
Bettag, Christoph [1 ]
Schatlo, Bawarjan [1 ]
Abboud, Tammam [1 ]
Behme, Daniel [2 ,3 ]
Bock, Christoph [1 ]
von der Brelie, Christian [1 ,4 ]
Rohde, Veit [1 ]
Mielke, Dorothee [1 ]
机构
[1] Univ Hosp Gottingen, Dept Neurosurg, Gottingen, Germany
[2] Univ Hosp Gottingen, Dept Neuroradiol, Gottingen, Germany
[3] Univ Hosp Magdeburg, Dept Neuroradiol, Magdeburg, Germany
[4] Johanniter Hosp Bonn, Dept Neurosurg, Bonn, Germany
关键词
5-Aminolevulinic acid; Endoscope; Fluorescence-guided surgery; Glioblastoma; 5-AMINOLEVULINIC ACID; RESECTION; EXTENT; ASSOCIATION; GLIOMAS;
D O I
10.1007/s00701-023-05862-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PurposeExtent of resection (EOR) predicts progression-free survival (PFS) and may impact overall survival (OS) in patients with glioblastoma. We recently demonstrated that 5-aminolevulinic acid-(5-ALA)-fluorescence-enhanced endoscopic surgery increase the rate of gross total resection. However, it is hitherto unknown whether fluorescence-enhanced endoscopic resection affects survival.MethodsWe conducted a retrospective single-center analysis of a consecutive series of patients who underwent surgery for non-eloquently located glioblastoma between 2011 and 2018. All patients underwent fluorescence-guided microscopic or fluorescence-guided combined microscopic and endoscopic resection. PFS, OS, EOR as well as clinical and demographic parameters, adjuvant treatment modalities, and molecular characteristics were compared between microscopy-only vs. endoscopy-assisted microsurgical resection.ResultsOut of 114 patients, 73 (65%) were male, and 57 (50%) were older than 65 years. Twenty patients (18%) were operated on using additional endoscopic assistance. Both cohorts were equally distributed in terms of age, performance status, lesion location, adjuvant treatment modalities, and molecular status. Gross total resection was achieved in all endoscopy-assisted patients compared to about three-quarters of microscope-only patients (100% vs. 75.9%, p=0.003). The PFS in the endoscope-assisted cohort was 19.3 months (CI95% 10.8-27.7) vs. 10.8 months (CI95% 8.2-13.4; p=0.012) in the microscope-only cohort. OS in the endoscope-assisted group was 28.9 months (CI95% 20.4-34.1) compared to 16.8 months (CI95% 14.0-20.9), in the microscope-only group (p=0.001).ConclusionEndoscope-assisted fluorescence-guided resection of glioblastoma appears to substantially enhance gross total resection and OS. The strong effect size observed herein is contrasted by the limitations in study design. Therefore, prospective validation is required before we can generalize our findings.
引用
收藏
页码:4221 / 4226
页数:6
相关论文
共 14 条
[1]   Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery [J].
Aldave, Guillermo ;
Tejada, Sonia ;
Pay, Eva ;
Marigil, Miguel ;
Bejarano, Bartolome ;
Idoate, Miguel A. ;
Diez-Valle, Ricardo .
NEUROSURGERY, 2013, 72 (06) :915-920
[2]   Endoscope-assisted visualization of 5-aminolevulinic acid fluorescence in surgery for brain metastases [J].
Bettag, Christoph ;
Hussein, Abdelhalim ;
Schatlo, Bawarjan ;
Barrantes-Freer, Alonso ;
Abboud, Tammam ;
Rohde, Veit ;
Mielke, Dorothee .
JOURNAL OF NEUROSURGERY, 2022, 137 (06) :1650-1655
[3]   Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery [J].
Bettag, Christoph ;
Schregel, Katharina ;
Langer, Philip ;
Thomas, Carolina ;
Behme, Daniel ;
Stadelmann, Christine ;
Rohde, Veit ;
Mielke, Dorothee .
NEUROSURGICAL FOCUS, 2021, 50 (01) :1-7
[4]   Endoscopic Fluorescence-Guided Resection Increases Radicality in Glioblastoma Surgery [J].
Bettag, Christoph ;
Hussein, Abdelhalim ;
Behme, Daniel ;
Maragkou, Theoni ;
Rohde, Veit ;
Mielke, Dorothee .
OPERATIVE NEUROSURGERY, 2020, 18 (01) :41-46
[5]   Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis [J].
Brown, Timothy J. ;
Brennan, Matthew C. ;
Li, Michael ;
Church, Ephraim W. ;
Brandmeir, Nicholas J. ;
Rakszawski, Kevin L. ;
Patel, Akshal S. ;
Rizk, Elias B. ;
Suki, Dima ;
Sawaya, Raymond ;
Glantz, Michael .
JAMA ONCOLOGY, 2016, 2 (11) :1460-1469
[6]  
Collaud Sabine, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P301, DOI 10.2174/1568011043352984
[7]   A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival [J].
Lacroix, M ;
Abi-Said, D ;
Fourney, DR ;
Gokaslan, ZL ;
Shi, WM ;
DeMonte, F ;
Lang, FF ;
McCutcheon, IE ;
Hassenbusch, SJ ;
Holland, E ;
Hess, K ;
Michael, C ;
Miller, D ;
Sawaya, R .
JOURNAL OF NEUROSURGERY, 2001, 95 (02) :190-198
[8]   Independent association of extent of resection with survival in patients with malignant brain astrocytoma [J].
McGirt, Matthew J. ;
Chaichana, Kaisorn L. ;
Gathinji, Muraya ;
Attenello, Frank J. ;
Than, Khoi ;
Olivi, Alessandro ;
Weingart, Jon D. ;
Brem, Henry ;
Quinones-Hinojosa, Alfredo .
JOURNAL OF NEUROSURGERY, 2009, 110 (01) :156-162
[9]   Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note [J].
Morshed, Ramin A. ;
Han, Seunggu J. ;
Lau, Darryl ;
Berger, Mitchel S. .
JOURNAL OF NEUROSURGERY, 2018, 128 (05) :1448-1453
[10]   Endoscopic-Assisted Visualization of 5-Aminolevulinic Acid-Induced Fluorescence in Malignant Glioma Surgery: A Technical Note [J].
Rapp, Marion ;
Kamp, Marcel ;
Steiger, Hans-Jakob ;
Sabel, Michael .
WORLD NEUROSURGERY, 2014, 82 (1-2) :E277-E279